Cell membrane proteins hide secret gateways that can be used to modify cell behavior. This has been demonstrated in a study ...

GPCRs are important because a significant portion of existing drugs target them to act on cells. In fact, 34% of FDA-approved drugs are based on these receptors.

Both ibuprofen and naproxen potently inhibit hTAS1R2–TAS1R3 receptors that sense sweetness in a dose-dependent manner. The ...

American Century Companies Inc. increased its position in shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) ...

Structure Therapeutics Inc.’s GPCR share price has dipped by 12.27%, which has investors questioning if this is right time to buy.

Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...

Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) has been given an average rating of “Buy” by the eight research ...

Professor Sun Jinpeng's team at Shandong University and collaborators published a research paper titled "Metabolic signaling of ceramides through the FPR2 receptor inhibits adipocyte thermogenesis" in ...

TX45 Phase 1b trial interim analysis demonstrated meaningful improvements in both left ventricular function and pulmonary hemodynamics in ...